Discover & Learn

Discover our tailor-made radiopharmacy solutions, and connect with our experts at booth #2023.

IBA specialists are available to discuss cyclotron and radiochemistry technologies, as well as integrated solutions.

This is an opportunity to exchange on ongoing projects, technical challenges and future development plans in radioisotope production.

At Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine, discover our end‑to‑end radiopharmacy solutions, from cyclotrons to radiochemistry, designed for reliable production.

Let’s exchange on your projects and challenges, and what comes next.

The Future of Astatine is here

At SNMMI 2026, discover the latest IBA Astatine-211 dedicated technologies —where precision, reliability, and performance come together for alpha-based targeted cancer therapies.

Be among the first to discover it and get the experts perspective.
Seats are limited → book your seat now
 

• Sunday, May 31 – 3.30 PM
• IBA booth #2023

Discover our end‑to‑end radiopharmacy solutions, designed for reliable production.

Let’s exchange on your projects and challenges, and what comes next.

Before setting up an in-house radiopharmacy, the CHU Québec – Université Laval relied on external providers for radiopharmaceuticals. It constrained its ability to provide patient access to novel theranostics radiopharmaceuticals. The Canadian hospital turned to IBA for a solution that could ensure consistent and flexible production while supporting both clinical care and research.